With osteoarthritis being the most common degenerative disease in pet animals, a very
broad panel of natural health products is available on the market for its management. The …

Osteoarthritis (OA) is a degenerative joint disease, affecting 32.5 million US adults or 242
million people worldwide. There is no cure for OA. Many animal and clinical trials showed …

Introduction There is currently no disease-modifying drug for osteoarthritis (OA), and some
safety concerns have been identified about the leading traditional drugs. Therefore …

Simple Summary Osteoarthritis (OA), the most common joint disease affecting humans and
animals, is a painful, degenerative, and inflammatory disease that affects synovial joints and …

Osteoarthritis (OA) is an age-related joint disease that includes gradual disruption of the
articular cartilage and the resulting pain. The present study was designed to test the effects …

The Canadian consensus guidelines on OA treatment were created from a diverse group of
experts, with a strong clinical and/or academic background in treating OA in dogs. The …

Robenacoxib is a veterinary‐approved non‐steroidal anti‐inflammatory drug (NSAID) of the
coxib group. It possesses anti‐hyperalgesic, anti‐inflammatory and anti‐pyretic properties …

Sodium dodecyl sulfonate polyacrylamide gel electrophoresis (SDS-PAGE), circular
dichroism spectroscopy (CD), transmission electron microscope (TEM) and atomic force …

The aim of the study was to evaluate the clinical efficacy of 30 days treatment of
undenatured type II collagen (UC-II®), compared to cimicoxib and to their combination, in …

Simple Summary Undenatured type II collagen and Boswellia serrata are feed supplements
that have been used for years in the multimodal management of osteoarthritis (OA), with the …